HYGEIA GROUP SA: SALE OF COMPANIES "STEM HEALTH SA" AND "STEM HEALTH HELLAS SA" COMPLETED

The company DIAGNOSTIC AND THERAPEUTIC CENTER OF ATHENS HYGEIA SA (hereinafter HYGEIA) and the company MITERA PRIVATE, GENERAL, MATERNITY/GYNECOLOGICAL & CHILDREN'S HOSPITAL SA (hereinafter MITERA) announce the signing of the final agreement for the sale of all controlling interest owned by HYGEIA (76%) to the company MEDICAL TECHNOLOGY STEM CELL BANK SA, trading under STEM HEALTH SA, and all controlling interest owned by MITERA (42%) to the company MEDICAL TECHNOLOGY STEM CELL BANK SA, trading under STEM HEALTH SA (hereinafter STEM Group companies), for a total token consideration of €1 (each transaction).

These transactions were carried out as part of the decision by the HYGEIA Group Management  to focus on the provision of purely hospitalization and diagnostic services from now on. It is also believed that said transactions will further improve the liquidity and financial position of HYGEIA Group, since it will stop financing the operating activities of the STEM Group companies.

Note that in the last published financial statements (June 2013), the STEM Group companies, which are active in the collection and storage of stem cells, represented 0.7% of HYGEIA Group's revenue. Furthermore, in the current fiscal year, the loss from the sale of the aforementioned interests (non-recurring results) will stand at €845 thou. for HYGEIA and €818 thou. for MITERA.